Yahoo
OTC Markets OTCPK - Delayed Quote USD

ProtoKinetix, Incorporated (PKTX)

0.0003 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
Chart Range Bar
Loading chart for PKTX
  • Previous Close 0.0003
  • Open 0.0063
  • Bid 0.0064 x 16917500
  • Ask 0.0075 x 4000000
  • Day's Range 0.0063 - 0.0063
  • 52 Week Range 0.0001 - 0.0124
  • Volume 2,962
  • Avg. Volume 28,717
  • Market Cap (intraday) 123,489
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) --
  • EPS (TTM) 0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications, such as targeted health care solutions, as well as AAGPs are used in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

www.protokinetix.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PKTX
95.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

PKTX
95.52%
S&P 500 (^GSPC)
11.11%

3-Year Return

PKTX
98.18%
S&P 500 (^GSPC)
81.91%

5-Year Return

PKTX
99.70%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -51.82%

  • Return on Equity (ttm)

    -123.01%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -393.65k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.12k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -189.66k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: